Journal of Neuroscience, Vol 1, 192-203, Copyright © 1981 by Society for Neuroscience
Neurotransmitter- and neuromodulator-dependent alterations in phosphorylation of protein I in slices of rat facial nucleus
AC Dolphin and P Greengard
Protein I is a neuronal phosphoprotein associated primarily with synaptic
vesicles. Regulation of its state of phosphorylation has been investigated
in slices of rat facial nucleus. This brainstem motor nucleus has a
facilitatory serotonergic input and contains no interneurons. Serotonin
(5-hydroxytryptamine, 5-HT, 10(-4) M), in the presence of the
phosphodiesterase inhibitor isobutylmethylxanthine (IBMX, 4 x 10(-5) M),
converted approximately 26% of Protein I in these slices from the
dephospho-form to the phospho-form. This effect was partially inhibited
using two classical 5-HT antagonists, mianserin added to the slices during
in vitro incubation and metergoline administered in vivo. The effect of
5-HT appeared to be Ca2+-dependent, unlike that of IBMX (10(-3) M).
Adenosine, its analog 2- chloroadenosine, and ATP also increased the
phosphorylation of Protein I in facial nucleus slices. 2-Chloroadenosine (5
x 10(-4) M) caused a 29% phosphorylation of Protein I, and this effect was
not dependent on extracellular Ca2+. The phosphorylation of Protein I
caused both by 2- chloroadenosine and by ATP was inhibited by the adenosine
antagonist 2'- deoxyadenosine. Results of additional experiments suggest
that the great majority of the Protein I in the facial nucleus is present
in presynaptic terminals other than the serotonergic afferents. It is
concluded that the stimulation by 5-HT and adenosine of Protein I
phosphorylation results largely from a direct action of these compounds on
those Protein I-containing terminals.